Home › Teva gains standing to challenge Mylan poison pill
 

Keywords :   


Teva gains standing to challenge Mylan poison pill

2015-06-19 15:52:18| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. has acquired a 4.61 percent stake in generic drug rival Mylan N.V., giving Teva standing to challenge Mylan's Dutch poison-pill defense against a hostile takeover.

Tags: challenge standing gains pill

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.05Groupe M6 launches M6+ free streaming platform
21.05Derrell Peel: So far so good, but be cautious of 2024 pasture and hay conditions
21.05Derrell Peel: So far so good, but be cautious of 2024 pasture and hay conditions
21.05Comcast to offer discounted Peacock, Netflix, Apple TV+ bundle
21.05Food price rises 'returning to normal'
21.05Stanford, Colo. State lead review of fire research
21.05Atlantic Tropical Weather Outlook
21.05Eastern North Pacific Tropical Weather Outlook
More »